140 related articles for article (PubMed ID: 30276721)
21. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
22. Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?
Horisberger K; Erben P; Ströbel P; Bohn B; Hahn M; Kähler G; Wenz F; Hochhaus A; Post S; Willeke F; Hofheinz RD
Onkologie; 2010; 33(8-9):439-44. PubMed ID: 20838059
[TBL] [Abstract][Full Text] [Related]
23. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Daniel ES; Gibbs P; Guerrieri M; Faragher I
Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
[TBL] [Abstract][Full Text] [Related]
24. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
[TBL] [Abstract][Full Text] [Related]
25. FGF8 and FGFR3 are up-regulated in hypertrophic chondrocytes: Association with chondrocyte death in deep zone of Kashin-Beck disease.
Liu H; Fang Q; Wang M; Wang W; Zhang M; Zhang D; He Y; Zhang Y; Wang H; Otero M; Ma T; Chen J
Biochem Biophys Res Commun; 2018 Jun; 500(2):184-190. PubMed ID: 29626475
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
27. CoA Synthase (
Ferrandon S; DeVecchio J; Duraes L; Chouhan H; Karagkounis G; Davenport J; Orloff M; Liska D; Kalady MF
Cancer Res; 2020 Jan; 80(2):334-346. PubMed ID: 31704889
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.
Gauglhofer C; Sagmeister S; Schrottmaier W; Fischer C; Rodgarkia-Dara C; Mohr T; Stättner S; Bichler C; Kandioler D; Wrba F; Schulte-Hermann R; Holzmann K; Grusch M; Marian B; Berger W; Grasl-Kraupp B
Hepatology; 2011 Mar; 53(3):854-64. PubMed ID: 21319186
[TBL] [Abstract][Full Text] [Related]
29. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
[TBL] [Abstract][Full Text] [Related]
30. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
[TBL] [Abstract][Full Text] [Related]
31. Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Yoshikawa K; Shimada M; Higashijima J; Nakao T; Nishi M; Takasu C; Kashihara H; Eto S; Bando Y
Anticancer Res; 2018 Mar; 38(3):1735-1739. PubMed ID: 29491110
[TBL] [Abstract][Full Text] [Related]
32. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
33. The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer.
Bhangu A; Wood G; Brown G; Darzi A; Tekkis P; Goldin R
Colorectal Dis; 2014 Apr; 16(4):O133-43. PubMed ID: 24617665
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
35. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
[TBL] [Abstract][Full Text] [Related]
36. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
[TBL] [Abstract][Full Text] [Related]
37. Molecular Predictors of Response to Neoadjuvant Chemoradiation for Rectal Cancer.
Kundel Y; Nasser NJ; Rath-Wolfson L; Purim O; Yanichkin N; Brenner R; Zehavi T; Nardi Y; Fenig E; Sulkes A; Brenner B
Am J Clin Oncol; 2018 Jun; 41(6):613-618. PubMed ID: 27740975
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Fujikawa H; Matsushita K; Okugawa Y; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Int J Oncol; 2012 Feb; 40(2):583-91. PubMed ID: 21922134
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
[TBL] [Abstract][Full Text] [Related]
40. Rab5C enhances resistance to ionizing radiation in rectal cancer.
Baptistella AR; Landemberger MC; Dias MVS; Giudice FS; Rodrigues BR; da Silva PPCE; Cassinela EK; Lacerda TC; Marchi FA; Leme AFP; Begnami MD; Aguiar S; Martins VR
J Mol Med (Berl); 2019 Jun; 97(6):855-869. PubMed ID: 30968159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
